• OPEN AN ACCOUNT
Indian Indices
Nifty
25,877.85 -176.05
(-0.68%)
Sensex
84,107.39 -297.07
( -0.35%)
Bank Nifty
58,031.10 -354.15
( -0.61%)
Nifty IT
35,906.40 -183.70
( -0.51%)
Global Indices
Nasdaq
47,543.42 -109.58
(-0.23%)
Dow Jones
6,843.58 -68.01
(-0.98%)
Hang Seng
51,378.02 70.37
(0.14%)
Nikkei 225
9,755.02 -1.12
(-0.01%)
Forex
USD-INR
88.22 -0.03
(-0.03%)
EUR-INR
102.62 -0.25
(-0.24%)
GBP-INR
116.65 -0.80
(-0.68%)
JPY-INR
0.58 0.00
(-0.12%)

EQUITY - MARKET SCREENER

Gujarat Themis Biosyn Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
506879
INE942C01045
22.7945967
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GUJTHEM
114.27
5092.49
EPS(TTM)
Face Value()
Div & Yield %
4.09
1
0.14
 

ceat ltd
Board of Acceleratebs India recommends final dividend
May 27,2025
Acceleratebs India announced that the Board of Directors of the Company at its meeting held on 26 May 2025, inter alia, have recommended the final dividend of Rs 0.2 per equity Share (i.e. 2%) , subject to the approval of the shareholders.